Takeshi Aoyama

7PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAdolescent healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 21, 2026
Systematic review of antiemetic therapy for low emetogenic chemotherapy: comparing 5-HT3 receptor antagonists and dexamethasone.

|Nov 05, 2025
Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC.

Kazuo Kobayashi, Takeru Wakatsuki, Erika Sugiyama

|Sep 30, 2025
Identification of high-risk age groups for cisplatin-induced nausea and vomiting in young patients with sarcoma.

Azusa Soejima, Koki Hashimoto, Kazuyoshi Kawakami

|Sep 07, 2023
Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study.

Takashi Yokokawa, Kenichi Suzuki, Daiki Tsuji

|Jun 06, 2022
Safety evaluation of fixed-dose nivolumab in patients with gastric cancer.

Yusuke Iikura, Takeshi Aoyama, Makoto Hiraide

|Feb 26, 2021
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers.

Kazuo Kobayashi, Erika Sugiyama, Eiji Shinozaki

Pageof 2

Frequent Collaborators

5 joint publications

Kazuyoshi Kawakami

4 joint publications

Kazuo Kobayashi

3 joint publications

Takashi Yokokawa

2 joint publications

Koki Hashimoto